Home   Health Tips   Health Concerns    Site Index    Search   Glossary    Contact Us

Visit our Health Index for More Subjects, Conditions and Answers

Benfotiamine Slowing and Blocking Diabetic Complication and Retinopathy

Benfotiamine Blocks Three Major Pathways of Hyperglycemic Damage and Prevents Experimental Diabetic Retinopathy

Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J,
Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M.

Medical Clinic V
School of Clinical Medicine
Mannheim, Germany.
Nat Med. 2003 Mar;9(3):294-9

Abstract

Three of the major biochemical pathways implicated in the pathogenesis of hyperglycemia induced vascular damage (the hexosamine pathway, the advanced glycation end product (AGE) formation pathway and the diacylglycerol (DAG)-protein kinase C (PKC) pathway) are activated by increased availability of the glycolytic metabolites glyceraldehyde-3-phosphate and fructose-6-phosphate. We have discovered that the lipid-soluble thiamine derivative benfotiamine can inhibit these three pathways, as well as hyperglycemia-associated NF-kappaB activation, by activating the pentose phosphate pathway enzyme transketolase, which converts glyceraldehyde-3-phosphate and fructose-6-phosphate into pentose-5-phosphates and other sugars. In retinas of diabetic animals, benfotiamine treatment inhibited these three pathways and NF-kappaB activation by activating transketolase, and also prevented experimental diabetic retinopathy. The ability of benfotiamine to inhibit three major pathways simultaneously might be clinically useful in preventing the development and progression of diabetic complications.

Return to Clinical Trails

Return to Neuropathy

STILL HAVE QUESTIONS?  CALL 888 758-5590  OR EMAIL AND GET YOUR QUESTIONS ANSWERED. 


If you would like to receive the McVitamins Weekly Newsletter,  Please Sign up by clicking here:  Newsletter Signup

We take privacy and security seriously, read about it here


 Search the site 

Home    Health Tips   Health Concerns   Site Index   Glossary

© 2000-2017  McVitamins.com
.  All Rights Reserved. Reproduction of this website in full or in part is prohibited without the express written permission of McVitaminsc.om

We have used our best judgment in compiling this information. The Food and Drug Administration may not have evaluated the information presented. Any reference to a specific product is for your information only and is not intended to diagnose, treat, cure, or prevent any disease